BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 202014)

  • 1. Lipid substrates for LCAT activity in liver disease.
    Salvioli G; Lugli R; Salati R
    Scand J Gastroenterol; 1977; 12(7):841-7. PubMed ID: 202014
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of heparin on lecithin: cholesterol acyltransferase and lipids in cholestasis.
    Rubiés-Prat J; Ras MR; Frisón JC; Miquel C; Masdeu S; Bacardi R
    Digestion; 1976; 14(3):250-5. PubMed ID: 955331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic secretion enzymes and electrophoretic lipoprotein fractions in liver disease.
    Tăpălagă D; Opincaru A; Cucuianu M
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):9-16. PubMed ID: 34311
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids in liver disease.
    Shahid A
    J Pak Med Assoc; 1992 Nov; 42(11):258-9. PubMed ID: 1479635
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoproteins in plasma from patients with low LCAT activity due to biliary obstruction.
    Danielsson B; Ekman R; Johansson BG; Nilsson-Ehle P; Petersson BG
    Scand J Clin Lab Invest Suppl; 1978; 150():214-7. PubMed ID: 218276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fatty acid makeup of the high-density lipoproteins in hyperalphalipoproteinemia].
    Gerasimova EN; Torkhovskaia TI; Ozerova IN; Khaltaev NG; Metel'skaia VA
    Vopr Med Khim; 1980; 26(5):650-6. PubMed ID: 7423882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The behavior of lecithin cholesterol acyltransferase (LCAT) in acute viral hepatitis and post-hepatitis cirrhosis].
    Falsetti F; Proto C; Fernicola C; Ielasi G
    Minerva Med; 1979 Jan; 70(5):399-404. PubMed ID: 440618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cholesterol esterification in liver disease.
    Blomhoff JP
    Scand J Gastroenterol; 1976; 11(8):753-6. PubMed ID: 1006148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism of high density lipoproteins. Studies in patients with compensated, postinfectious liver cirrhosis].
    Daerr W
    Fortschr Med; 1989 Feb; 107(4):46, 49-50. PubMed ID: 2925142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lecithin : cholesterol acyl transfer (LACT) and fatty acid composition of lecithin and cholesterol esters in young male myocardial infarction survivors.
    Wiklund O; Gustafson A
    Atherosclerosis; 1979 May; 33(1):1-8. PubMed ID: 223597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipids and lipoproteins in liver disease.
    McIntyre N
    Gut; 1978 Jun; 19(6):526-30. PubMed ID: 355066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lecithin:cholesterol acyltransferase activity in relation to lipoprotein concentration and lipid composition.
    Leiss O; Murawski U; Egge H
    Scand J Clin Lab Invest Suppl; 1978; 150():77-84. PubMed ID: 218279
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphatidylcholine substrate specificity of lecithin: cholestrol acyltransferase-in high density lipoproteins and in lipids dispersions.
    Yokoyama S; Murase T; Akanuma Y
    J Biochem; 1977 Sep; 82(3):719-24. PubMed ID: 199582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incorporation of 4-14C-labeled cholesterol into the cholesterol ester fractions of plasma lipoproteins in patients with cirrhosis of the liver (author's transl)].
    Weizel A
    Klin Wochenschr; 1976 Aug; 54(15):739-42. PubMed ID: 979072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cholesterol, free cholesterol, HDL, LDL, triglycerides, LCAT. Evaluation of some risk factors for cardiovascular diseases].
    Andreoli D; Lattuada L; Giovanelli E; Persico D
    Quad Sclavo Diagn; 1982 Jun; 18(2):127-31. PubMed ID: 7167633
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the degradation of lipoprotein-X.
    Patsch W; Patsch JR; Kunz F; Sailer S; Braunsteiner H
    Eur J Clin Invest; 1977 Dec; 7(6):523-30. PubMed ID: 204492
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoaffinity-isolation of plasma lecithin-cholesterol acyltransferase (LCAT) from patients with hepatic cirrhosis.
    Chawla D; Malik AM; Lima VL; Owen JS
    Biochem Soc Trans; 1998 May; 26(2):S147. PubMed ID: 9649822
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma lecithin-cholesterol acyltransferase activity (LCAT) in late schistosomiasis and chronic liver disease].
    Huang MX
    Zhonghua Nei Ke Za Zhi; 1985 Jan; 24(1):31-3, 63. PubMed ID: 3979186
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.
    Breier C; Lisch HJ; Braunsteiner H
    Klin Wochenschr; 1983 Sep; 61(18):929-31. PubMed ID: 6632732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.